Skip to content

The Impact of Virtual Reality and Kaleidoscope in Children During Vaccination

The Impact of Virtual Reality and Kaleidoscope Usage on Pain, Fear, and Anxiety in Children During Routine Vaccination: A Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06112600
Enrollment
126
Registered
2023-11-01
Start date
2021-09-15
Completion date
2023-06-30
Last updated
2023-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Pediatric Patient, Fear, Virtual Reality, Nursing Caries

Brief summary

This study was designed to examine the effects of using virtual reality and kaleidoscope during routine vaccination in children aged 48 months on pain, fear, and anxiety. Children aged 48 months who were to receive the measles-mumps-rubella vaccine were randomized into three groups. Accordingly, the study sample consisted of a virtual reality group with 42 children, a kaleidoscope group with 42 children, and a control group with 42 children, totaling 126 children. Fear and pain were evaluated by both the researcher and the child before and after the procedure. Anxiety was assessed by the child after the procedure. The Wong Baker Faces Pain Rating Scale was used for pain, the Children's Fear Scale for fear, and the Child Anxiety Scale-State Version for anxiety.

Interventions

PROCEDUREVR

Virtual reality glasses were used as a distraction method for children during vaccination.

PROCEDUREKaleidoscope

Kaleidoscope toys were used as a distraction method for children during vaccination.

Sponsors

Ege University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This prospective, randomised controlled study

Eligibility

Sex/Gender
ALL
Age
48 Months to 48 Months
Healthy volunteers
No

Inclusion criteria

* being 48 months * being conscious (with the ability to communicate).

Exclusion criteria

* Having a physical and psychological condition that prevents them from wearing glasses to view VR; * Having a visual problem * Having mental or physical disabilities * Taking any analgesics, sedatives, or anticonvulsants in the past 24 hours * Having chronic or life-threatening disease * Refusing the VR or kaleidoscope intervention during vaccine injection.

Design outcomes

Primary

MeasureTime frameDescription
Procedural Pain1 yearJust before vaccination, both the child and the researcher used the Wong-Baker Faces Scale. This scale uses in children aged 3 and older to rate pain severity. This numeric rating scale ranges from 0 to 10. Faces show emotions from smiling (0 = very happy/no pain) to crying (10 = hurts worst). The child can choose the face that best illustrates the physical pain.
Fear1 yearJust before vaccination, both the child and the researcher used the Children's Fear Scale. The scale includes five drawn facial expressions ranging from a neutral expression (0=no anxiety) to a frightened face (4=severe anxiety) and has been validated for the Turkish population The scale allows for evaluations on a scale from 0 to 4.
Anxiety1 yearJust before vaccination, both the child and the researcher used the Children's Anxiety Meter-State. It is drawn like a thermometer with a bulb at the bottom. It includes horizontal lines going up to the top (0-10). Children are asked to mark how feel right now to measure state anxiety. Higher values represent higher anxiety.

Secondary

MeasureTime frameDescription
Parental satisfaction1 yearparental satisfaction scores measured with the 10-point Likert type scale. Minimum score is 0, maximum score is 10.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026